Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-04-18 Sale | 2022-04-19 7:59 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 11,500 | $31.87 | $366,530 | 355,727 (Indirect Direct) | View |
2022-03-22 Sale | 2022-03-22 8:05 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 18,437 | $34.17 | $629,987 | 26,263 (Direct) | View |
2022-02-23 Sale | 2022-02-24 8:00 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 14,500 | $34.34 | $497,905 | 34,700 (Direct) | View |
2022-01-25 Sale | 2022-01-26 7:53 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 14,500 | $35.68 | $517,378 | 49,200 (Direct) | View |
2021-12-20 Sale | 2021-12-22 8:01 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 44,500 | $44.54 | $1,982,131 | 2,260,326 (Indirect Direct) | View |
2021-11-23 Sale | 2021-11-24 7:59 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 14,500 | $36.08 | $523,160 | 78,200 (Direct) | View |
2021-11-01 Sale | 2021-11-03 7:59 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 20,557 | $28.55 | $586,966 | 76,437 (Direct) | View |
2021-10-21 Sale | 2021-10-25 8:00 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 196 | $28 | $5,488 | 96,994 (Direct) | View |
2021-10-15 Sale | 2021-10-19 8:01 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 1,836 | $28.01 | $51,424 | 97,190 (Direct) | View |
2021-09-23 Sale | 2021-09-27 8:00 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 6,411 | $28.14 | $180,374 | 99,026 (Direct) | View |
2021-09-01 Sale | 2021-09-03 8:01 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 20,252 | $28.66 | $580,518 | 105,437 (Direct) | View |
2021-08-27 Sale | 2021-08-31 8:00 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 14,663 | $28.13 | $412,481 | 125,689 (Direct) | View |
2021-08-23 Sale | 2021-08-25 8:04 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 8,585 | $28.06 | $240,890 | 140,352 (Direct) | View |
2021-06-14 Sale | 2021-06-16 6:48 pm | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 29,000 | $28.5 | $826,534 | 148,937 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-08 Gift | 2024-08-09 8:00 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 885,600 | $0 | 590,400 (Direct) | View |
2024-03-07 Option Award | 2024-03-08 7:57 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 590,400 | $0 | 590,400 (Direct) | View |
2023-12-05 Option Award | 2023-12-07 8:20 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 30,000 | $0 | 58,903 (Direct) | View |
2023-03-09 Gift | 2023-03-10 7:51 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 509,994 | $0 | 692,000 (Direct) | View |
2023-03-09 Option Award | 2023-03-10 7:51 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 346,000 | $0 | 692,000 (Direct) | View |
2022-04-15 Ownership | 2023-03-10 7:50 pm | N/A 2032-03-11 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 528,750 | $0 | 352,500 (Direct) | View |
2022-04-18 Exercise | 2022-04-19 7:59 pm | N/A 2030-05-01 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 11,500 | $0 | 355,727 (Direct) | View |
2022-04-18 Exercise | 2022-04-19 7:59 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 11,500 | $4.23 | 355,727 (Direct) | View |
2022-03-11 Option Award | 2022-03-14 7:59 pm | N/A 2032-03-11 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 362,500 | $0 | 397,200 (Direct) | View |
2021-12-20 Exercise | 2021-12-22 8:01 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 30,000 | $4.3 | 2,260,326 (Direct) | View |
2021-12-20 Exercise | 2021-12-22 8:01 pm | N/A 2025-06-11 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 30,000 | $0 | 2,260,326 (Direct) | View |
2021-12-02 Gift | 2021-12-22 8:01 pm | N/A 2025-06-11 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 2,867,884 | $0 | 2,260,326 (Direct) | View |
2021-11-22 Exercise | 2021-11-24 7:59 pm | 2015-11-13 2021-12-16 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 16,263 | $0 | 78,200 (Direct) | View |
2021-11-22 Exercise | 2021-11-24 7:59 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 16,263 | $12.45 | 78,200 (Direct) | View |
2021-03-01 Option Award | 2021-03-03 4:16 pm | N/A 2031-03-01 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 144,000 | $0 | 144,000 (Direct) | View |
2020-07-23 Option Award | 2020-07-24 7:24 pm | N/A 2030-07-23 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 1,035,424 | $0 | 177,937 (Direct) | View |
Ownership | 2020-07-23 7:26 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 0 | $0 | 1,008,850 (Direct) | View |